ALPN
Price
$38.65
Change
+$1.20 (+3.20%)
Updated
Mar 27, 6:59 PM EST
42 days until earnings call
BPMC
Price
$94.79
Change
+$5.12 (+5.71%)
Updated
Mar 27, 6:59 PM EST
34 days until earnings call
Ad is loading...

Compare predictions ALPN vs BPMC

Header iconALPN vs BPMC Comparison
Open Charts ALPN vs BPMCBanner chart's image
Alpine Immune Sciences
Price$38.65
Change+$1.20 (+3.20%)
Volume$478.86K
CapitalizationN/A
Blueprint Medicines
Price$94.79
Change+$5.12 (+5.71%)
Volume$340.63K
CapitalizationN/A
View a ticker or compare two or three
ALPN vs BPMC Comparison Chart

Loading...

ALPNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
BPMCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ALPN vs. BPMC commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALPN is a Hold and BPMC is a StrongBuy.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (ALPN: $38.65 vs. BPMC: $94.79)
Brand notoriety: ALPN and BPMC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALPN: 53% vs. BPMC: 97%
Market capitalization -- ALPN: $2.53B vs. BPMC: $5.8B
ALPN [@Biotechnology] is valued at $2.53B. BPMC’s [@Biotechnology] market capitalization is $5.8B. The market cap for tickers in the [@Biotechnology] industry ranges from $576.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALPN’s FA Score shows that 1 FA rating(s) are green whileBPMC’s FA Score has 0 green FA rating(s).

  • ALPN’s FA Score: 1 green, 4 red.
  • BPMC’s FA Score: 0 green, 5 red.
According to our system of comparison, ALPN is a better buy in the long-term than BPMC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALPN’s TA Score shows that 3 TA indicator(s) are bullish while BPMC’s TA Score has 4 bullish TA indicator(s).

  • ALPN’s TA Score: 3 bullish, 5 bearish.
  • BPMC’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BPMC is a better buy in the short-term than ALPN.

Price Growth

ALPN (@Biotechnology) experienced а -3.93% price change this week, while BPMC (@Biotechnology) price change was +7.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.41%. For the same industry, the average monthly price growth was +5.97%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

ALPN is expected to report earnings on May 09, 2024.

BPMC is expected to report earnings on May 01, 2024.

Industries' Descriptions

@Biotechnology (+4.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ALPN with price predictions.
OPEN
A.I.dvisor published
a Summary for BPMC with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BPMC($5.8B) has a higher market cap than ALPN($2.53B). ALPN YTD gains are higher at: 102.781 vs. BPMC (2.765). ALPN has higher annual earnings (EBITDA): -31.41M vs. BPMC (-470.36M). BPMC has more cash in the bank: 711M vs. ALPN (327M). ALPN has less debt than BPMC: ALPN (9.91M) vs BPMC (332M). BPMC has higher revenues than ALPN: BPMC (249M) vs ALPN (58.9M).
ALPNBPMCALPN / BPMC
Capitalization2.53B5.8B44%
EBITDA-31.41M-470.36M7%
Gain YTD102.7812.7653,718%
P/E RatioN/A17.70-
Revenue58.9M249M24%
Total Cash327M711M46%
Total Debt9.91M332M3%
FUNDAMENTALS RATINGS
ALPN vs BPMC: Fundamental Ratings
ALPN
BPMC
OUTLOOK RATING
1..100
8322
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
87
Overvalued
PROFIT vs RISK RATING
1..100
576
SMR RATING
1..100
9399
PRICE GROWTH RATING
1..100
3438
P/E GROWTH RATING
1..100
10071
SEASONALITY SCORE
1..100
n/a3

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALPN's Valuation (60) in the Biotechnology industry is in the same range as BPMC (87). This means that ALPN’s stock grew similarly to BPMC’s over the last 12 months.

ALPN's Profit vs Risk Rating (5) in the Biotechnology industry is significantly better than the same rating for BPMC (76). This means that ALPN’s stock grew significantly faster than BPMC’s over the last 12 months.

ALPN's SMR Rating (93) in the Biotechnology industry is in the same range as BPMC (99). This means that ALPN’s stock grew similarly to BPMC’s over the last 12 months.

ALPN's Price Growth Rating (34) in the Biotechnology industry is in the same range as BPMC (38). This means that ALPN’s stock grew similarly to BPMC’s over the last 12 months.

BPMC's P/E Growth Rating (71) in the Biotechnology industry is in the same range as ALPN (100). This means that BPMC’s stock grew similarly to ALPN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALPNBPMC
RSI
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
70%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
70%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 7 days ago
85%
Bullish Trend 1 day ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 23 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
N/A
View a ticker or compare two or three
Ad is loading...
ALPNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
BPMCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSMVX35.350.58
+1.67%
Congress Small Cap Growth Retail
CIMAX24.150.21
+0.88%
American Funds Income Fund of Amer 529A
CSDRX13.230.08
+0.61%
Columbia Global Opportunities Adv
EGWRX16.27N/A
N/A
Allspring Discovery Small Cap Gr R6
SMMSX25.53-0.02
-0.08%
Invesco Summit S

ALPN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALPN has been loosely correlated with AURA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ALPN jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALPN
1D Price
Change %
ALPN100%
+3.20%
AURA - ALPN
41%
Loosely correlated
+0.92%
KOD - ALPN
41%
Loosely correlated
+5.21%
AXON - ALPN
39%
Loosely correlated
-1.13%
FATE - ALPN
37%
Loosely correlated
+7.00%
ACLX - ALPN
36%
Loosely correlated
+0.54%
More

BPMC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPMC has been loosely correlated with NTLA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMC jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPMC
1D Price
Change %
BPMC100%
+5.71%
NTLA - BPMC
46%
Loosely correlated
+2.82%
RARE - BPMC
45%
Loosely correlated
+3.06%
ORMP - BPMC
44%
Loosely correlated
+4.41%
SNDX - BPMC
43%
Loosely correlated
+7.60%
AGIO - BPMC
43%
Loosely correlated
+0.34%
More